Siltuximab (INN, trade name Sylvant; also known as CNTO 328, anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse...
10 KB (852 words) - 17:33, 22 January 2024
treatment for iMCD is anti-IL-6 therapy with siltuximab (or tocilizumab, if siltuximab is not available). Siltuximab is the only FDA-approved treatment for...
23 KB (2,400 words) - 07:29, 11 May 2024
directed against the IL6-receptor. The second, siltuximab (Sylvant), is directed against IL-6 itself. Siltuximab is approved for treatment of human immunodeficiency...
12 KB (1,289 words) - 19:20, 4 December 2023
features of iMCD, and blockade of the IL-6 pathway using the medications siltuximab and tocilizumab effectively treats some patients with iMCD. However, many...
27 KB (3,189 words) - 07:30, 11 May 2024
silperisone (INN) Silphen siltenzepine (INN) silteplase (INN) Siltussin-CF siltuximab (USAN) Silvadene simaldrate (INN) simenepag (USAN, INN) simendan (INN)...
4 KB (261 words) - 16:35, 20 March 2022
Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See...
22 KB (1,841 words) - 22:50, 30 April 2024
Ravulizumab Risankizumab Ritlecitinib Rozanolixizumab Sarilumab Satralizumab Siltuximab Siponimod Sirukumab Spesolimab Sutimlimab Tildrakizumab Tofacitinib Upadacitinib...
7 KB (299 words) - 13:45, 27 April 2024
Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab...
3 KB (367 words) - 15:37, 25 January 2024
Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See...
14 KB (1,578 words) - 14:00, 26 February 2024
antibody preparation directed against B cells bearing the CD20 antigen, or siltuximab, a monoclonal antibody preparation directed against interleukin-6, may...
25 KB (2,239 words) - 19:32, 23 November 2023